Literature DB >> 4616883

Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer.

G C Lewis, N H Slack, R Mortel, I D Bross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4616883     DOI： 10.1016/0090-8258(74)90028-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  5 in total

Review 1.  Adjuvant progestagens for endometrial cancer.

Authors:  Pierre Pl Martin-Hirsch; Andrew Bryant; Sarah L Keep; Henry C Kitchener; Richard Lilford
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 6: Cancer of the uterus and vulva.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-06       Impact factor: 1.798

Review 3.  Carcinoma of the endometrium.

Authors:  B M Southcott
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Pathophysiology and management of endometrial hyperplasia and carcinoma.

Authors:  Y S Fu; J C Gambone; J S Berek
Journal:  West J Med       Date:  1990-07

5.  Adjuvant hormonal therapy for stage I endometrial cancer.

Authors:  L Gien; J Kwon; T K Oliver; M Fung-Kee-Fung
Journal:  Curr Oncol       Date:  2008-06       Impact factor: 3.677
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.